NorthStrive Biosciences Announces Positive Phase III Drug Discovery Results
NorthStrive Biosciences announced that four compounds significantly increased ANT1 expression in human skeletal muscle cells. The results support the development of muscle-preserving therapeutics.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day